As our experiments indicated that NF-κB/p65 is important for the cell migratory and invasive properties of breast cancer cells (Figs 1 and 2), we questioned whether NF-κB/p65 inhibition would alter EMT-related gene expression. Here, NFKB1 is linked to breast carcinoma.